Mangoceuticals Announces the Launch of “PeachesRx” - a Women's Telehealth Brand Focused on Personalized Wellness and GLP-1 Weight Loss Treatments

Core Viewpoint - Mangoceuticals, Inc. has launched PeachesRx, a women's health and wellness brand, focusing on telemedicine solutions tailored to women's unique health needs, particularly in weight management through GLP-1 receptor agonists [1][2][4]. Market Opportunity - The global GLP-1 market for weight management is projected to exceed $48 billion by 2030, with women making up the majority of users [3]. - The global women's health market was valued at $49.33 billion in 2024 and is expected to reach $68.53 billion by 2030, growing at a 5.1% CAGR [3]. Product Offering - PeachesRx will initially focus on compounded GLP-1 receptor agonists, which are effective for weight loss by regulating appetite and glucose metabolism [2]. - The brand aims to provide accessible and affordable telehealth solutions specifically designed for women's metabolic needs [2][3]. Strategic Positioning - PeachesRx is positioned to capture the growing demand for women's telehealth services, leveraging a HIPAA-compliant telemedicine platform for seamless access to treatments [3][4]. - The company plans to expand its offerings beyond weight management to include areas such as sexual health, hair growth, and hormone therapy in the future [5]. Leadership Insights - The CEO of Mangoceuticals emphasized the opportunity in women's health, noting that over 60% of telehealth users are female, indicating a strong market for personalized healthcare solutions [4][5]. - The COO highlighted the commitment to transforming access to women's healthcare by providing innovative, affordable, and medically supervised treatments [5].